Our studies showed that EphA2 was expressed abundantly in L1T2, SLK-KSHV, and KS-IMM cells and that Hsp90 inhibitors reduced EphA2 expression. This evidence concerns the gene HSP90AB1 and Kaposi's sarcoma.